What Thiols Tell Us About Type 1 Diabetes Complications in Children

Thiols are sulfur-containing compounds naturally found in the body that play protective roles—helping cells defend themselves against damage, supporting cell survival, and regulating important cellular processes. When type 1 diabetes leads to a serious complication called diabetic ketoacidosis (DKA), the body's chemistry becomes severely imbalanced. Researchers wanted to know whether thiol levels change during DKA and whether these changes might signal how severe the condition is or predict kidney problems.

Scientists studied 72 children with DKA—19 with mild cases, 25 with moderate cases, and 28 with severe cases. They measured thiol and related compounds in blood samples and compared these measurements to clinical markers of disease severity and kidney function.

The findings revealed a clear pattern: native thiols (a specific type of thiol) were higher in children with more severe ketoacidosis. Additionally, two measurements of thiol balance—called homeostatic index 1 and index 3—differed significantly across the three severity groups.

Among the 34 children who had reduced kidney function during their DKA episode, native thiols, total thiols, and homeostatic index 3 were all lower. This suggested an association between thiol levels and kidney health in this population.

The analysis found that elevated native thiol levels were associated with a lower risk of disease getting worse and a lower risk of kidney function decline in children with DKA. While this is an important observation, it describes a correlation found in this group of children—not a proven causal relationship or a treatment target.

This study adds to our understanding of the chemical processes happening in children's bodies during serious diabetes emergencies. By identifying which molecular markers appear in children with more severe outcomes, researchers create a foundation for future work aimed at better predicting and preventing complications like kidney damage.

The findings do not currently change how DKA is treated or monitored. However, they may eventually help guide efforts to identify children at highest risk and develop new protective strategies. More research will be needed to confirm these associations and explore whether targeting thiol metabolism could benefit patients.

Source: Journal of nutritional science and vitaminology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.